Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells

FASEB Journal

Volumn 24, Issue 5, 2010, Pages 1411-1418

  Fainaru, Ofer ^a,b   Almog, Nava ^e   Yung, Chong Wing ^a,b   Nakai, Kei ^b   Montoya Zavala, Martin ^a,b,c   Abdollahi, Amir ^e,f,g   D'Amato, Robert ^a,b   Ingber, Donald E ^a,b,c,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD UNIVERSITY   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Immune cells; Vasculogenesis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MATRIGEL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH; ANIMAL; CELL MOTION; DRUG SCREENING; IMMUNOLOGY; IMMUNOMODULATION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

MUS; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DENDRITIC CELLS; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOMODULATION; MICE; MICE, TRANSGENIC; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952299622     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-147025     Document Type: Article

References (29)

1. Banchereau, J., and Steinman, R. M. (1998) Dendritic cells and the control of immunity. Nature 392, 245-252
2. Steinman, R. M., Hawiger, D., and Nussenzweig, M. C. (2003) Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711
3. Marigo, I., Dolcetti, L., Serafini, P., Zanovello, P., and Bronte, V. (2008) Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells. Immunol. Rev. 222, 162-179
4. Gabrilovich, D. (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat. Rev. Immunol. 4, 941-952
5. Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., and Zitvogel, L. (2005) Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med. 202, 919-929
6. Sica, A., and Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117, 1155-1166
7. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., and Carbone, D. P. (1998) Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood 92, 4150-4166 (Pubitemid 28544331)
8. Conejo-Garcia, J. R., Benencia, F., Courreges, M. C., Kang, E., Mohamed-Hadley, A., Buckanovich, R. J., Holtz, D. O., Jenkins, A., Na, H., Zhang, L., Wagner, D. S., Katsaros, D., Caroll, R., and Coukos, G. (2004) Tumor-infiltrating dendritic cell precursors recruited by a β-defensin contribute to vasculogenesis under the influence of Vegf-A. Nat. Med. 10, 950-958
9. Coukos, G., Benencia, F., Buckanovich, R. J., and Conejo-Garcia, J. R. (2005) The role of dendritic cell precursors in tumour vasculogenesis. Br. J. Cancer 92, 1182-1187
10. Fainaru, O., Adini, A., Benny, O., Adini, I., Short, S., Bazinet, L., Nakai, K., Pravda, E., Hornstein, M. D., D'Amato, R. J., and Folkman, J. (2008) Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis. FASEB J. 22, 522-529
11. Plaks, V., Birnberg, T., Berkutzki, T., Sela, S., BenYashar, A., Kalchenko, V., Mor, G., Keshet, E., Dekel, N., Neeman, M., and Jung, S. (2008) Uterine DCs are crucial for decidua formation during embryo implantation in mice. J. Clin. Invest. 118, 3954-3965
12. Nakai, K., Fainaru, O., Bazinet, L., Pakneshan, P., Benny, O., Pravda, E., Folkman, J., and D'Amato, R. J. (2008) Dendritic cells augment choroidal neovascularization. Invest. Ophthalmol. Vis. Sci. 49, 3666-3670
13. Folkman, J., Watson, K., Ingber, D., and Hanahan, D. (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61
14. Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu, S., Vuthoori, S., Ko, K., Zavala, F., Pamer, E. G., Littman, D. R., and Lang, R. A. (2002) In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 17, 211-220
15. Lutz, M. B., Suri, R. M., Niimi, M., Ogilvie, A. L., Kukutsch, N. A., Rossner, S., Schuler, G., and Austyn, J. M. (2000) Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30, 1813-1822
16. Adini, A., Fainaru, O., Udagawa, T., Connor, K. M., Folkman, J., and D'Amato, R. J. (2009) Matrigel cytometry: a novel method for quantifying angiogenesis in vivo. J. Immunol. Methods 342, 78-81
17. Naumov, G. N., Bender, E., Zurakowski, D., Kang, S. Y., Sampson, D., Flynn, E., Watnick, R. S., Straume, O., Akslen, L. A., Folkman, J., and Almog, N. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J. Natl. Cancer Inst. 98, 316-325
18. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. (1992) A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67, 519-528
19. Dranoff, G. (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 4, 11-22
20. Jinushi, M., and Dranoff, G. (2007) Triggering tumor immunity through angiogenesis targeting. Clin. Cancer Res. 13, 3762-3764
21. Condeelis, J., and Pollard, J. W. (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266
22. Murdoch, C., Muthana, M., Coffelt, S. B., and Lewis, C. E. (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8, 618-631
23. Huarte, E., Cubillos-Ruiz, J. R., Nesbeth, Y. C., Scarlett, U. K., Martinez, D. G., Buckanovich, R. J., Benencia, F., Stan, R. V., Keler, T., Sarobe, P., Sentman, C. L., and Conejo-Garcia, J. R. (2008) Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Res. 68, 7684-7691
24. Folkman, J. (2003) Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3, 643-651
25. De Palma, M., and Naldini, L. (2006) Role of haematopoietic cells and endothelial progenitors in tumour angiogenesis. Biochim. Biophys. Acta 1766, 159-166
26. De Palma, M., Venneri, M. A., Galli, R., Sergi Sergi, L., Politi, L. S., Sampaolesi, M., and Naldini, L. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211-226
27. Bennett, C. L., and Clausen, B. E. (2007) DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 28, 525-531
28. Carmi, Y., Voronov, E., Dotan, S., Lahat, N., Rahat, M. A., Fogel, M., Huszar, M., White, M. R., Dinarello, C. A., and Apte, R. N. (2009) The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J. Immunol. 183, 4705-4714
29. Melief, C. J. (2008) Cancer immunotherapy by dendritic cells. Immunity 29, 372-383